HYPERGEN: GENETICS OF LEFT VENTRICULAR HYPERTROPHY
HYPERGEN:左心室肥大的遗传学
基本信息
- 批准号:6200180
- 负责人:
- 金额:$ 100.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-10 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:cardiovascular disorder epidemiology clinical research disease /disorder proneness /risk echocardiography family genetics gene environment interaction genetic markers genetic screening genetic susceptibility human genetic material tag human population genetics human subject hypertension linkage mapping quantitative trait loci ventricular hypertrophy
项目摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) Left ventricular (LV)
hypertrophy is a common condition that profoundly affects morbidity and
mortality from cardiovascular diseases. The long-term objective of this study,
the HyperGEN (Genetics of LV Hypertrophy) study is to identify genetic
predictors influencing susceptibility to LV hypertrophy and cardiac
dysfunction. During the initial project period, echocardiography was performed
on 3,000 black and white participants in the parent HyperGEN study, a
multicenter study designed to determine the genetics of hypertension. As a
result, most study participants were family members ascertained on
hypertension. The investigators carried out genome-wide linkage analyses, and
identified chromosomal regions with a high probability of harboring genetic
loci contributing the interindividual variation in LV and myocardial
contractility.
In this renewal application, the investigators propose to extend this work with
three complementary specific aims to further understanding of the genetics of
echocardiography phenotypes. Specific Aim 1 proposes to further characterize
genomic regions contributing to interindividual variation in LV mass and
related cardiographic phenotypes among 1,900 hypertensive sibs, 400 of their
normotensive offspring, and an additional 720 offspring to be recruited by the
parent HyperGEN study beginning in Summer, 2000. To enhance statistical power
to detect genetic linkage and association for narrowing genomic regions, the
investigators will conduct echocardiography on 480 of these offspring who are
not being phenotyped by HyperGEN.
Specific Aim 2 will consist of identifying positional candidate genes within
the implicated genomic regions based on their known function and chromosomal
location. To facilitate this aim, the investigators will use results from rat
models to identify regions of homology in humans with know gene locations in
the rat. Specific Aim 3 will investigate whether genes contributing to LV mass
in hypertensives also contribute to the phenotype in normotensives, and thereby
characterize the full spectrum of LV mass and related cardiac phenotypes. This
will require using the randomly ascertained sample from the HyperGEN study to
recruit and examine sibling and offspring of normotensive individuals who have
LV mass in the upper 75th percentile of the LV mass distribution. The
investigators will examine allelic variation in the candidate genes identified
in specific Aim 2 in this normotensive sample ascertained on increased LV mass.
Finally, the investigators will replicate these findings in a second
population-based sample of normotensive with LV hypertrophy and their age and
sex matched controls. Overall, the study represents a complementary approach,
from animal to human, to further understanding of the genetic architecture of
LV hypertrophy.
描述:(改编自《调查者摘要》)左心室(LV)
肥大是一种常见的疾病,它深刻地影响着发病率和
心血管疾病的死亡率。这项研究的长期目标是
HyperGEN(左心室肥厚遗传学)研究是为了确定遗传
影响左室肥厚和心肌肥厚易感性的预测因素
功能障碍。在最初的项目阶段,进行了超声心动图检查。
在父母HyperGEN研究中的3000名黑人和白人参与者中,
旨在确定高血压遗传学的多中心研究。作为一名
结果,大多数研究参与者是被确定的家庭成员。
高血压。研究人员进行了全基因组的连锁分析,并
识别出高概率携带遗传基因的染色体区域
左心室和心肌的个体间变异的基因座
伸缩性。
在这份续签申请中,调查人员提议将这项工作扩展到
三个相辅相成的具体目标,以进一步了解人类的遗传学
超声心动图表型。具体目标1建议进一步描述
导致左心室重量和左心室重量个体间差异的基因组区域
1900名高血压同胞中400人的相关心动图表型
血压正常的后代,以及额外的720名后代将由
家长HyperGEN研究于2000年夏季开始。增强统计力量
为了检测缩小基因组区域的遗传连锁和关联,
调查人员将对其中480名子女进行超声心动图检查,他们是
没有被HyperGEN表型。
具体目标2将包括识别
基于已知功能和染色体的隐含基因组区域
地点。为了促进这一目标,调查人员将使用来自老鼠的结果
识别具有已知基因位置的人类同源区域的模型
那只老鼠。特定目标3将调查是否有导致左心室重量的基因
高血压患者的表型也有助于正常血压患者的表型,因此
描述左心室肿块的全谱和相关的心脏表型。这
将要求使用从HyperGEN研究中随机确定的样本来
招募和检查血压正常的人的兄弟姐妹和后代
左心室质量分布的上75%百分位数。这个
研究人员将检查已确定的候选基因中的等位基因变异
在特定的目标2中,在这个血压正常的样本中,确定了左心室质量的增加。
最后,调查人员将在一秒钟内复制这些发现
正常血压伴左室肥厚的人群样本及其年龄和
性别匹配的对照组。总体而言,这项研究代表了一种补充方法,
从动物到人类,以进一步了解生物的遗传结构
左心室肥厚。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donna K Arnett其他文献
1030-139 Prevalence and correlates of mitral regurgitation in hypertensive patients: The hypergen study
- DOI:
10.1016/s0735-1097(04)91806-2 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Zhi Bin Li;Richard B Devereux;Jennifer E Liu;Dalane W Kitzman;Albert Oberman;Paul N Hopkins;Charles C Gu;Donna K Arnett - 通讯作者:
Donna K Arnett
1142-179 Body fat distribution influences cardiac output in normotensive and hypertensive overweight individuals: The hyperGEN study
- DOI:
10.1016/s0735-1097(04)92168-7 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Giovanni de Simone;Richard B Devereux;Marcello Chinali;Vittorio Palmieri;Albert Oberman;Dalane W Kitzman;Paul N Hopkins;D.C Rao;Donna K Arnett - 通讯作者:
Donna K Arnett
Donna K Arnett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donna K Arnett', 18)}}的其他基金
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
9250286 - 财政年份:2016
- 资助金额:
$ 100.02万 - 项目类别:
Genetic and Molecular Markers of Methotrexate Efficacy and Toxicity in Early...
早期甲氨蝶呤功效和毒性的遗传和分子标记...
- 批准号:
8304146 - 财政年份:2011
- 资助金额:
$ 100.02万 - 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
8300134 - 财政年份:2010
- 资助金额:
$ 100.02万 - 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
8509004 - 财政年份:2010
- 资助金额:
$ 100.02万 - 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
8130808 - 财政年份:2010
- 资助金额:
$ 100.02万 - 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
9120549 - 财政年份:2010
- 资助金额:
$ 100.02万 - 项目类别:
Epigenetic Determinants of Lipid Response to Dietary Fat and Fenofibrate
膳食脂肪和非诺贝特脂质反应的表观遗传决定因素
- 批准号:
7949793 - 财政年份:2010
- 资助金额:
$ 100.02万 - 项目类别:
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
非诺贝特和膳食脂肪的脂质反应的全基因组关联研究
- 批准号:
8129753 - 财政年份:2008
- 资助金额:
$ 100.02万 - 项目类别:
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
非诺贝特和膳食脂肪的脂质反应的全基因组关联研究
- 批准号:
9316688 - 财政年份:2008
- 资助金额:
$ 100.02万 - 项目类别:
Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat
非诺贝特和膳食脂肪的脂质反应的全基因组关联研究
- 批准号:
7682091 - 财政年份:2008
- 资助金额:
$ 100.02万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 100.02万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 100.02万 - 项目类别:














{{item.name}}会员




